Vertex Pharmaceuticals Inc / Ma

Ashton Thomas Private Wealth, LLC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

2,503

Value ($000)

1,135

Weight

0.0%

2022 Q1 - 2025 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	1,135	0.0%	2,503	12/31/2025
2025 Q3	11/4/2025	945	0.0%	2,414	9/30/2025
2025 Q2	8/1/2025	945	0.0%	2,122	6/30/2025
2025 Q1	5/16/2025	1,136	0.0%	2,342	3/31/2025
2024 Q4	2/7/2025	840	0.0%	2,087	12/31/2024
2024 Q3	11/5/2024	1,065	0.1%	2,291	9/30/2024
2024 Q2	8/7/2024	1,096	0.1%	2,339	6/30/2024
2024 Q1	4/22/2024	939	0.1%	2,246	3/31/2024
2023 Q4	4/22/2024	792	0.0%	1,946	12/31/2023
2023 Q3	4/22/2024	314	0.0%	903	9/30/2023
2023 Q2	4/23/2024	314	0.0%	892	6/30/2023
2023 Q1	4/23/2024	273	0.0%	868	3/31/2023
2022 Q4	4/22/2024	268	0.0%	929	12/31/2022
2022 Q3	4/22/2024	253	0.0%	873	9/30/2022
2022 Q2	4/22/2024	266	0.0%	944	6/30/2022
2022 Q1	4/22/2024	232	0.0%	889	3/31/2022